[PDF][PDF] Seronegative spondyloarthropathy-studies from the Asia Pacific region
HS Howe, L Zhao, YW Song, L Springer… - ANNALS-ACADEMY …, 2007 - annals.edu.sg
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
[引用][C] Seronegative spondyloarthropathy-studies from the Asia pacific region
H HS - Ann Acad Med Singapore, 2007 - cir.nii.ac.jp
Seronegative spondyloarthropathy-Studies from the Asia Pacific region
SH Hwee, L Zhao, WS Yeong… - Annals of the …, 2007 - snucm.elsevierpure.com
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
Seronegative spondyloarthropathy--studies from the Asia Pacific region.
HS Howe, L Zhao, YW Song, L Springer… - Annals of the …, 2007 - europepmc.org
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
Seronegative spondyloarthropathy--studies from the Asia Pacific region
HS HOWE, L ZHAO, YW SONG… - Annals of the …, 2007 - pesquisa.bvsalud.org
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
Seronegative spondyloarthropathy--studies from the Asia Pacific region
HS Howe, L Zhao, YW Song… - Annals of the …, 2007 - pubmed.ncbi.nlm.nih.gov
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
[PDF][PDF] Seronegative Spondyloarthropathy–Studies from the Asia Pacific Region
HS Howe, L Zhao, YW Song, L Springer… - Ann Acad Med …, 2007 - annals.edu.sg
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
Seronegative spondyloarthropathy--studies from the Asia Pacific region
HS Howe, L Zhao, YW Song, L Springer, J Edmonds… - 2007 - s-space.snu.ac.kr
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
Seronegative spondyloarthropathy--studies from the Asia Pacific region.
HS Howe, L Zhao, YW Song, L Springer… - Annals of the …, 2007 - wprim.whocc.org.cn
Recent therapeutic advances, in particular the use of anti-tumour necrosis factor (anti-TNF)
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …
agents, have revived interest in the seronegative spondyloarthropathies (SpA), a group of …